FUJIFILM Unveils $1.2 Billion Biopharmaceutical Facility in North Carolina

A new biopharmaceutical manufacturing facility opened in Holly Springs, North Carolina, marking a significant investment in the life sciences sector. FUJIFILM Diosynth Biotechnologies announced the launch of the facility on Wednesday, which is part of a multi-billion-dollar investment strategy aimed at enhancing biomanufacturing capabilities in the region. The facility is expected to create nearly 700 jobs and establish itself as the largest cell culture biopharmaceutical contract development and manufacturing organization (CDMO) facility in North America.

The new facility will play a crucial role in bolstering the supply chain and expanding the production scale of various advanced medicines. Holly Springs officials highlighted its importance as a cornerstone of the company’s global kojoX manufacturing network. The announcement regarding the facility was initially made in March 2023, with the site being part of the larger Holly Springs Business Park.

Major Investments Fueling Growth

In a move reflecting confidence in the North Carolina biotech landscape, Johnson & Johnson announced an investment of $2 billion in the FUJIFILM facility in August. This investment will facilitate an expansion of at least 160,000 square feet, creating approximately 120 additional jobs in the state. Joaquin Duato, Chairman and Chief Executive Officer of Johnson & Johnson, emphasized the company’s commitment to strengthening its manufacturing presence in the U.S., which currently boasts more facilities than any other country.

“We continue to expand our investment in the U.S. to lead the next era of healthcare innovation,” Duato stated. This expansion is part of a broader strategy to enhance the company’s capabilities in response to the growing demand for biopharmaceutical production.

FUJIFILM’s initial investment of $1.2 billion into the facility underscores its commitment to advancing biotechnological research and manufacturing in North Carolina. The company has also established a partnership with the North Carolina Biotech Center, which includes a $100,000 in-kind donation to N.C. State University. This donation will enable students and industry professionals to gain practical training through access to state-of-the-art technology, such as advanced bioreactor controllers.

Future Prospects for Biotech in North Carolina

The opening of this facility aligns with the state’s growing focus on biotechnology and artificial intelligence (AI). Earlier this month, Governor Josh Stein announced an executive order aimed at leveraging AI technology to bolster the biotech sector. Stein envisions a future where AI can unlock economic growth, attract innovation, and improve government efficiency.

An advisory team has been established to oversee companies operating in both AI and biotechnology, indicating a strategic approach towards enhancing the state’s technological landscape. “If we do this right, we can use AI to help unlock economic growth, attract innovation, improve government efficiency, and prepare our workforce for the jobs of tomorrow,” Governor Stein remarked.

As the new FUJIFILM facility begins operations, it is set to play a pivotal role in shaping the future of biopharmaceutical manufacturing in North Carolina and beyond. The investment signifies a robust commitment to developing advanced healthcare solutions and nurturing a skilled workforce ready to meet the challenges of modern biotechnology.